Luminex Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Results are generated in a single workflow from a patient sample, which enables rapid detection for the differential diagnosis of a single pathogen. DiaSorin Expects 2022 Revenue Growth From Base Business, Luminex as COVID-19 Testing Declines Premium DiaSorin CEO Carlo Rosa said that demand for the firm's SARS-CoV-2 tests peaked during the Omicron wave in December and January but declined sharply in recent weeks. DiaSorin 2021 Revenues Rise 41 Percent on SARS-CoV-2, Luminex Sales Growth Luminex contributed €195.0 million to DiaSorin's revenues in 2021 and saw strong performance from its Aries and Verigene molecular diagnostic platforms. Luminex Gets CE Mark for Gastrointestinal Pathogen Panel The molecular multiplex panel is designed to detect 16 pathogens associated with gastrointestinal infections in stool samples. Genetic Analysis Receives CE Mark for Microbiome Test on Luminex Magpix Instrument Receipt of the CE mark will provide the Norwegian firm access to the large number of labs that already have the platform, expanding its addressable market, it said. Nov 11, 2021 DiaSorin Q3 Revenues Rise 51 Percent on Luminex Acquisition, Recovery of Non-COVID Test Sales Jul 30, 2021 DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand May 14, 2021 DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand Apr 13, 2021 With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence Premium Apr 12, 2021 DiaSorin to Acquire Luminex for $1.8B Mar 4, 2021 Luminex Obtains FDA Emergency Use Authorization for Expanded Respiratory Panel With SARS-CoV-2 Feb 25, 2021 Luminex Shares Surge on Rumor of Acquisition by DiaSorin Feb 19, 2021 Luminex Nabs $11.3M From BARDA to Develop Test for SARS-CoV-2, Flu, RSV Feb 9, 2021 Luminex Moving Ahead With EUA Applications Despite Deprioritization of SARS-CoV-2 Test Submission Premium Feb 8, 2021 Luminex Q4 Revenues Rise 23 Percent; FDA Deprioritizes EUA Submission for COVID-19 Test Jan 14, 2021 JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Jan 12, 2021 Luminex Preliminary Q4 Revenues Increase 23 Percent on MDx Strength Nov 5, 2020 Luminex Q3 Revenues Rise 35 Percent on Coronavirus Testing Demand Oct 7, 2020 Luminex Preliminary Q3 Revenues Rise 35 Percent on Pandemic-Related Demand Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 5, 2020 Luminex Responds to FDA Warning Letter While Ramping SARS-CoV-2 Test Manufacturing Premium Aug 4, 2020 Luminex Q2 Revenues Rise 32 Percent on Pandemic-Related Sales Jul 8, 2020 Luminex Preliminary Q2 Revenues Rise More Than 30 Percent on Pandemic-Related Sales Jun 30, 2020 FDA Issues Warning Letter to Luminex Load More Breaking News 23andMe Fiscal Q4 Revenues Increase 14 Percent Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii Allogeneic Stem Cell Transplant Outcomes Improve With Diverse Gut Microbes, Immune Cells CorePath Laboratories, Cizzle Biotechnology Partner on Lung Cancer Blood Test Becton Dickinson Gets CE-IVD Mark for High-Throughput COVID/Flu PCR Test The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.